Episode 1349: David Sinclair

TL;DR: A credentialed Harvard geneticist promotes supplements (NMN, resveratrol) in which he holds commercial interests, while making longevity claims that other scientists have repeatedly characterized as overhyped or unsupported by evidence in humans.

David Sinclair is a real Harvard professor with legitimate genetics credentials. The problem isn’t his pedigree — it’s that he uses Rogan’s massive platform to promote supplements and “age reversal” claims that mainstream aging researchers have publicly disputed, while glossing over his significant financial conflicts of interest.

The Guest

David Sinclair, Ph.D. — Professor in the Department of Genetics, co-Director of the Paul F. Glenn Center for the Biology of Aging, Harvard Medical School.
Author of Lifespan: Why We Age And Why We Don’t Have To (2019), promoted during the episode.
Co-founder/advisor with commercial stakes in multiple longevity supplement and biotech companies (Sirtris, InsideTracker, Animal Biosciences, and others).

The Core Problems

1. Resveratrol claims that have not held up

Sinclair tells Rogan he takes resveratrol daily and presents it as a credible longevity intervention.

What independent researchers have found:

Pacholec et al. (2010), Journal of Biological Chemistry: Showed that resveratrol’s purported activation of SIR2/sirtuins was an artifact of the fluorescent assay used in Sinclair’s early work — resveratrol is not a direct SIR2 activator. Link
NIH Interventions Testing Program: Resveratrol failed to extend lifespan in mice across multiple independent trials.
Bioavailability: Oral resveratrol is rapidly metabolized; circulating levels in humans are extremely low.
Sirtris saga: GSK acquired Sinclair’s company Sirtris for $720M in 2008 to develop resveratrol-based drugs, then shut the program down in 2013 after the science failed to pan out.

2. NMN / NAD+ boosters pitched as anti-aging

Sinclair discusses NMN (nicotinamide mononucleotide) as a longevity supplement he personally takes.

No randomized controlled trial in humans has demonstrated that NMN extends lifespan or “reverses aging.”
Charles Brenner, Ph.D. (discoverer of the NR pathway, City of Hope) has repeatedly criticized Sinclair’s NAD+/NMN claims as scientifically overstated. See his peer-reviewed critique of Lifespan: Brenner, Archives of Gerontology and Geriatrics (2022) — “A Science-Based Review of the World’s Best-Selling Book on Aging.”

3. Undisclosed or under-disclosed commercial conflicts

Sinclair has financial relationships with companies selling the very supplements he discusses.
In 2024, after a controversy over claims that an Animal Biosciences dog supplement “reversed aging,” Sinclair resigned as president of the Academy for Health and Lifespan Research following a wave of member resignations and a public rebuke from peers. Wall Street Journal coverage / NMN.com summary
Dr. Matt Kaeberlein (University of Washington, leading aging researcher) called the “proven to reverse aging in dogs” claim “a lie.”

4. “Age reversal” rhetoric outpaces the evidence

Throughout the episode, Sinclair frames aging as essentially a solvable software problem and implies near-term human age reversal.

The 2026 Time feature on the longevity field summarizes mainstream skepticism: human “biological age” reversal remains unproven, and existing epigenetic clocks measure correlates, not causal aging. Time, 2026
Independent labs have struggled to replicate key claims from Sinclair’s lab going back to 2003.

Joe Rogan’s Role

Rogan does not seriously challenge Sinclair on any of the substantive scientific disputes.

He does not raise the failed Sirtris program or GSK’s abandonment of the resveratrol drug pipeline.
He does not ask about Sinclair’s financial stakes in the supplements being discussed.
He does not bring up that other prominent aging researchers (Brenner, Kaeberlein, others) have publicly disagreed with Sinclair’s claims.
He repeatedly expresses awe and asks follow-ups framed as “wow, so I should take this?” rather than “what’s the strongest evidence against this?”

The result is essentially a long-form infomercial for NMN and resveratrol with a Harvard logo attached.

Real-World Harm

This episode (and Sinclair’s subsequent JRE appearances) is widely credited with driving a massive consumer market for NMN supplements — products that are expensive, largely unregulated, and lack human RCT evidence for the benefits implied.
Listeners with high cholesterol heard Sinclair casually endorse his personal statin use alongside unproven supplements, blurring the line between evidence-based medicine and personal experimentation.
The framing “a Harvard professor takes this” lends authority that the underlying data does not support — exactly the pattern Brenner warned about in his peer-reviewed critique.

Why It Matters

Credentials are not a substitute for evidence. When a Harvard professor promotes supplements he profits from on the world’s largest podcast — and the host asks zero hard questions — millions of listeners walk away thinking the science is settled when it is, at best, contested and, at worst, debunked.